Determining "acceptable uncertainty:" A case study of uncertain diagnosis in cystic fibrosis newborn screening

确定“可接受的不确定性”：囊性纤维化新生儿筛查中不确定诊断的案例研究

• 批准号: 206172
• 负责人: Marshall Jennifer A
• 金额: $ 7.65万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-10-01 至 2012-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=206172&lang=en
• 关键词: Bioethics; Communication Of Uncertainty; Genetic Testing; Health Services Research; Healthcare Ethics; Newborn Screening; Population Health; Risk Communication; Uncertain Diagnosis; Uncertainty Measures

Newborn screening (NBS) is used to identify infants with treatable disorders so that they may benefit from early detection and treatment. Cystic fibrosis (CF), determined by genetic testing, is often part of NBS programs because early diagnosis can improv

新生儿筛查（NBS）用于识别患有可治疗疾病的婴儿，以便他们可以从早期发现和治疗中受益。囊性纤维化（CF），通过基因检测确定，通常是国家统计局计划的一部分，因为早期诊断可以改善